Emcure to acquire remaining stake in Zuventus Healthcare
The transaction is expected to close in Q2 FY 2026
The transaction is expected to close in Q2 FY 2026
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
The Q1 2025 also witnessed a successful launch of Allegra D
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home
The merged entity ‘Aster DM Quality Care’ will be jointly controlled by Aster Promoters and Blackstone
Genomics is transforming the future of modern medicine and treatment modalities across specialties
David joins HCTI with a distinguished career of over 22 years of corporate finance experience
Subscribe To Our Newsletter & Stay Updated